Century Sage Scientific Holdings Limited (1450.HK)
HKD 1.0
(1.01%)
HKD 1.0
(1.01%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 182.98 Million | -2.08 Million | 7.8 Million | -1.61 Million | -2.5 Million | 68.89 Million |
| Net Income | 139.51 Million | -9.2 Million | -61.61 Million | -97.53 Million | -84.32 Million | -35.44 Million |
| Depreciation & Amortization | 30.53 Million | 8.48 Million | 7.98 Million | 10.11 Million | 10.12 Million | 10.49 Million |
| Deferred income taxes | - | 66.72 Million | -74 Million | -30.51 Million | -167.48 Million | -103.36 Million |
| Stock-based compensation | 83.71 Million | 23.42 Million | 93 Thousand | 1.52 Million | 2.37 Million | -1.06 Million |
| Change in working capital | -44.03 Million | -90.15 Million | 73.91 Million | 28.98 Million | 165.11 Million | 103.68 Million |
| Other non-cash items | -4.21 Million | -1.35 Million | 61.43 Million | 85.79 Million | 71.69 Million | 93.85 Million |
| Investing Cash Flow | -74.47 Million | 32.34 Million | 4.28 Million | -3.18 Million | -2.2 Million | 20.94 Million |
| Investments in PPE | -15.84 Million | -4.81 Million | -371 Thousand | -906 Thousand | -1.92 Million | -6.55 Million |
| Acquisitions | -49.02 Million | 744 Thousand | -7000.00 | 3.2 Million | -588 Thousand | 29.11 Million |
| Investment purchases | -10 Million | -39.6 Million | - | - | - | - |
| Sales/Maturities of investments | - | 38.86 Million | - | - | - | - |
| Other Investing Activities | 408 Thousand | 37.15 Million | 4.66 Million | -5.47 Million | 307 Thousand | -1.61 Million |
| Financing Cash Flow | -10.27 Million | -34.83 Million | 36.09 Million | 5 Million | -47.82 Million | -84.2 Million |
| Debt repayment | -7.75 Million | -83.23 Million | -104.56 Million | -100.95 Million | -149.64 Million | -162.8 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 8.94 Million | - | - | - |
| Other Financing Activities | -1.01 Million | 48.4 Million | 131.72 Million | 105.95 Million | 101.81 Million | 78.6 Million |
| Accounts receivables | -60.79 Million | -90.59 Million | 63.24 Million | 7.3 Million | 137.68 Million | 95.14 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -9.4 Million | 446 Thousand | 10.66 Million | 21.68 Million | 27.42 Million | 8.54 Million |
| Other working capital | 26.16 Million | - | - | - | - | - |
| Cash at beginning of period | 50.92 Million | 54.55 Million | 6.57 Million | 6.46 Million | 59.45 Million | 57.98 Million |
| Cash at end of period | 149.53 Million | 50.92 Million | 54.55 Million | 6.57 Million | 6.46 Million | 59.45 Million |
| Capital Expenditure | -15.84 Million | -4.81 Million | -371 Thousand | -906 Thousand | -1.92 Million | -6.55 Million |
| Effect of forex changes on cash | 369 Thousand | 950 Thousand | -208 Thousand | -98 Thousand | -443 Thousand | -4.16 Million |
| Net cash flow / Change in cash | 98.6 Million | -3.62 Million | 47.98 Million | 109 Thousand | -52.98 Million | 1.46 Million |
| Free Cash Flow | 167.13 Million | -6.89 Million | 7.43 Million | -2.52 Million | -4.43 Million | 62.33 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 85.07 Million | 75.28 Million | 139.51 Million | 44.18 Million | -9.2 Million | 17.79 Million |
| Depreciation & Amortization | 9.54 Million | 26.77 Million | 30.53 Million | 3.75 Million | 8.48 Million | 5.56 Million |
| Deferred income taxes | - | - | - | - | 66.72 Million | 85.17 Million |
| Stock-based compensation | 26.89 Million | 32.33 Million | 83.71 Million | 51.38 Million | 23.42 Million | 4.97 Million |
| Change in working capital | - | -70.19 Million | -44.03 Million | - | -90.15 Million | -90.15 Million |
| Other non-cash items | -101.25 Million | 48.67 Million | -4.21 Million | -29.19 Million | -1.35 Million | 81.39 Million |
| Investing Cash Flow | -10.92 Million | -34.78 Million | -74.47 Million | -39.69 Million | 32.34 Million | -6.13 Million |
| Investments in PPE | -7.49 Million | -6.04 Million | -15.84 Million | -6.67 Million | -4.81 Million | -3.63 Million |
| Acquisitions | - | -17 Million | -49.02 Million | -32.02 Million | 744 Thousand | - |
| Investment purchases | - | - | -10 Million | - | -39.6 Million | - |
| Sales/Maturities of investments | - | - | - | - | 38.86 Million | - |
| Other Investing Activities | -3.42 Million | -11.73 Million | 408 Thousand | -985 Thousand | 37.15 Million | -2.49 Million |
| Financing Cash Flow | 49.68 Million | 834 Thousand | -10.27 Million | -11.11 Million | -34.83 Million | 4.58 Million |
| Debt repayment | -49.68 Million | - | -7.75 Million | -11.11 Million | -83.23 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 834 Thousand | -1.01 Million | -11.11 Million | 48.4 Million | 4.58 Million |
| Accounts receivables | - | -60.79 Million | -60.79 Million | - | -90.59 Million | -90.59 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | -9.4 Million | -9.4 Million | - | 446 Thousand | 446 Thousand |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 149.53 Million | 70.43 Million | 50.92 Million | 50.92 Million | 54.55 Million | 39.82 Million |
| Cash at end of period | 208.24 Million | 70.43 Million | 149.53 Million | 70.43 Million | 50.92 Million | 56.43 Million |
| Capital Expenditure | -7.49 Million | -6.04 Million | -15.84 Million | -6.67 Million | -4.81 Million | -3.63 Million |
| Effect of forex changes on cash | -313 Thousand | 178 Thousand | 369 Thousand | 191 Thousand | 950 Thousand | -1.41 Million |
| Net cash flow / Change in cash | 58.7 Million | - | 98.6 Million | 19.51 Million | -3.62 Million | 16.61 Million |
| Free Cash Flow | 12.76 Million | 106.82 Million | 167.13 Million | 63.44 Million | -6.89 Million | 15.94 Million |
SPKTF
GNFTF
INDB
26490K
AIP
ANVS